Brazil Breaks Patent on Merck’s Efavirenz AIDS Drug (Update3) (Bloomberg.com)
Brazil Breaks Patent on Merck’s Efavirenz AIDS Drug (Update3) (Bloomberg.com)
May 4 (Bloomberg) — Brazilian President Luiz Inacio Lula da Silva broke the patent on Merck & Co’s AIDS drug Efavirenz after the company’s offer to cut prices failed to satisfy demands from the country’s health ministry.